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Abstract  1 
 2 
Purpose: The ‘traffic light’ color designation of differential light sensitivity used in a number of 3 
microperimeters does not encompass the conventional Total and Pattern Deviation probability 4 
analyses adopted by standard automated perimetry.  We determined whether the color 5 
designation is indicative of abnormality as represented by the ‘gold standard’ Pattern Deviation 6 
probability analysis.  7 
Methods:  Total and Pattern Deviation probability levels, using two different methods, were 8 
derived at each of 40 stimulus locations, within 7° eccentricity, from 66 ocular healthy 9 
individuals (66 eyes) who had undergone microperimetry with the Macular Integrity 10 
Assessment microperimeter.  The probability levels were applied to the corresponding fields 11 
from each of 45 individuals (45 eyes) with AMD and evaluated in relation to the color 12 
designation.  13 
Results:  Sensitivities designated in orange encompassed the entire range of Pattern 14 
Deviation probability levels (from normal to p≤1%).  Those designated in green were mostly 15 
normal; those in red/black generally corresponded to the ≤1% probability level.   16 
Conclusions:  The green and the red/black designations are generally indicative of normal 17 
and abnormal probability values, respectively.  The orange designation encompassed all 18 
probability outcomes and should not be relied upon for visual field interpretation. The 19 
evidence base indicates replacement of the color designation of sensitivity in AMD by Total 20 
Deviation and Pattern Deviation analyses.   21 
Translational Relevance: The use of Total and Pattern Deviation probability analyses is not 22 
universal in all microperimeters and the derivation of these values indicates that color coding 23 
will lead to errors in evaluating visual field loss. 24 
  25 
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Introduction 26 
Microperimetry is becoming increasingly popular for the assessment of the differential light 27 
sensitivity in macular disease 1–8. The principal advantage of microperimetry compared to 28 
standard automated perimetry (SAP) is the provision of fundus tracking which adjusts the 29 
position of each stimulus location to account for fixation instability and/ or for eccentric 30 
fixation, both of which are common in late stage macular disease. Additionally, the measured 31 
sensitivity at any given stimulus location is superimposed, in real time, upon the fundus 32 
image thereby providing an indication of the topographical relationship between visual 33 
function and fundal abnormality.  34 
 35 
The clinical interpretation of SAP at each stimulus location is based upon the difference 36 
between the measured sensitivity and the corresponding age-corrected normal value. The 37 
probability of a given difference lying outside of the normal range is used to indicate 38 
abnormality.  Overall loss is identified with the Total Deviation probability map and focal loss 39 
with the Pattern Deviation probability map. The Pattern Deviation map is derived from the 40 
Total Deviation map by the general height adjustment9,10. This type of analysis is also 41 
fundamental to other types of perimetry including Frequency Doubling Technology 42 
perimetry11 and Short-wavelength Automated Perimetry12,13.   43 
 44 
Only one commercial microperimeter, the Compass (CenterVue, Padova, Italy), uses the 45 
Total and Pattern Deviation probability analyses14.  The remaining microperimeters 46 
represent the measured sensitivity at each stimulus location by a continuous scale of color 47 
designation.  The color designation represents the absolute value of sensitivity, but the 48 
normal value, to which the latter is referenced, varies as a function of eccentricity and of 49 
age15,16. In addition, the extent of the deviation from normality associated with a given 50 
probability level varies as a function of location.  The inference is that green, orange and red 51 
are indicative of normal, suspect and abnormal outcomes.  This impression is reinforced by 52 
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the standard color designation for the probability levels used in optical coherence 53 
tomography, e.g. for peripapillary retinal nerve fibre layer, macular ganglion cell inner 54 
plexiform layer complex thickness and macular thicknesses, in which normality is indicated 55 
by green and abnormality at p≤0.01 by red, respectively.  It would be useful to determine the 56 
extent to which the color designation can indicate abnormality compared to that of the 57 
Pattern Deviation probability analysis.   58 
 59 
The derivation of the Total and Pattern Deviation probability levels at each stimulus location 60 
is based upon ordinary least squares univariate regression of the measured sensitivity 61 
against age.  Two different approaches have been utilised:  the age-specific method, which 62 
generates the deviation values, corresponding to each probability level, for each year of age 63 
17–21 based upon the prediction intervals of the regression line; and the central tendency 64 
method, which generates the deviation values by adjusting the measured sensitivity to that 65 
of either the mean 9,16 or the median 22 of the distribution at each location, using the 66 
regression coefficient.  The probability levels associated with the deviations are then 67 
generated either from the prediction intervals of the compiled distribution or empirically if the 68 
distribution is skewed. For example, in the central tendency method, the measured 69 
sensitivity at a given location for an individual of any given age is adjusted to that of the 70 
mean or median age of the sample using the regression coefficient of sensitivity against age. 71 
The deviation from the age-adjusted sensitivity is then compared to that of the corresponding 72 
normal limits and a probability value assigned. Such an approach is used in the Humphrey 73 
Field Analyzer. 74 
 75 
Given the comorbidity of cataract and age-related macular degeneration (AMD), the 76 
separation of overall from focal loss is essential. The omission in commercially available 77 
microperimetry of probability analyses for overall and for focal loss is of particular concern 78 
given the obvious potential of the technique in the management of macular disease i.e. the 79 
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color designation does not separate focal loss from that due to cataract. Furthermore,  a 80 
deviation at the paracentral locations of less than 1dB from the age-corrected normal values 81 
derived by the central tendency method in SAP can account for a change in probability level 82 
from 5% to 1% 23.   Thus, a significant loss could be overlooked when considering the 83 
absolute value of sensitivity.  The use of the Mean Deviation, Pattern Standard Deviation, 84 
mean Total Deviation and mean Pattern Deviation have been applied to the visual field from 85 
patients with AMD 24–26. The indices are summary measures of the visual field and do not 86 
provide a topographical representation of the location and spatial extent of the abnormality, 87 
which in the current study, is indicated by Pattern Deviation probability analysis.  Knowledge 88 
of the spatial location and extent of a defect is a fundamental principle of perimetry and is of 89 
considerable importance in AMD, given the patchy nature of the visual field loss.  The 90 
concept of Total and Pattern Deviation analysis has been illustrated for several clinical cases 91 
of AMD 22,26 but has not been described for a larger cohort or in relation to the color 92 
designation of absolute sensitivity. 93 
 94 
For the evaluation of visual field loss in the absence of normative values, it would be 95 
clinically useful to determine the extent to which the color designation could indicate 96 
abnormality compared to that of the ‘gold standard’ Pattern Deviation probability analysis.  97 
The aims of the study, therefore, were twofold.  Firstly, to derive, for a commercial 98 
microperimeter that uses a “traffic light” color designation, the Total and Pattern Deviation 99 
values associated with the 5%, 2% and 1% probability levels, respectively, using both the 100 
age-specific and the central tendency methods.  Secondly, to evaluate, in individuals with 101 
AMD, the correspondence between the color designation of sensitivity used by 102 
microperimetry and the Pattern Deviation probability analysis derived by the age-specific and 103 
the central tendency methods.  104 
 105 
Methods 106 
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The study utilised a prospective observational case series design in an institutional setting.  107 
Written informed consent was obtained from each individual prior to enrolment in the study 108 
and after explanation of the nature and possible consequences of the study.  The study 109 
adhered to the tenets of the Declaration of Helsinki, and subsequent revisions, for research 110 
involving human subjects and the protocol was prospectively approved by the Cardiff 111 
University Research Ethics and Audit Committee and by the National Health Service South 112 
East Wales Research Ethics Committee. 113 
 114 
 115 
Ocular healthy individuals 116 
Sixty-six ocular healthy individuals were consecutively recruited on the basis of 117 
approximately equal numbers per decade of age 27.   The individuals were recruited from 118 
members of senior citizen and religious centers in Cardiff, UK, and from administrative staff 119 
at Cardiff University.   120 
 121 
Each individual conformed to rigid inclusion criteria comprising: refractive error ≤ 5 dioptres 122 
sphere and 3 dioptres cylinder; visual acuity of better than or equal to 0.10 logMAR (6/7.5 123 
Snellen) for those aged up to 60 years, and better than, or equal to, 0.18 (6/9) for those 124 
aged greater than 60 years; normally reacting pupils; normal anterior segments; crystalline 125 
lens appearance by LOCS III of better than or equal to Grade 2 cortical, Grade 2 nuclear 126 
color and opalescence and Grade 1 posterior subcapsular 28; intraocular pressures ≤ 127 
21mmHg; normal optic nerve head and fundal appearances; normal visual fields; no 128 
previous or current ocular disease, trauma or surgery including cataract extraction and 129 
intraocular lens implantation; no history of diabetes mellitus or intracerebral disorder; no 130 
systemic medication known to affect visual function; and no family history of glaucoma.  One 131 
eye of each individual was selected at random for the study. 132 
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 133 
 134 
Individuals with age-related macular degeneration 135 
The case series comprised 45 consecutively presenting individuals with AMD who were 136 
attending the macular clinics at the Cardiff Eye Unit, University Hospital of Wales, Cardiff, 137 
UK, and who had volunteered to take part in the study.  138 
 139 
The inclusion criteria for the eyes with AMD were identical to those for the ocular healthy 140 
individuals, with the exception of wider criteria for visual acuity of better than or equal to 0.60 141 
logMAR (6/24 Snellen) and crystalline lens appearance by LOCS III of not greater than 142 
Grade 3 cortical, Grade 4 nuclear color and opalescence and Grade 3 posterior 143 
subcapsular28.  Individuals with pseudophakia were excluded. 144 
 145 
One eye of each individual was selected at random for the study.  If only one eye met the 146 
eligibility criteria, then that eye was selected.  The stage of AMD in the selected eye was 147 
classified according to the Beckman scale29.   148 
 149 
Clinical data collection 150 
Each individual from each group was required to attend for two visits, completed within a 151 
maximum of three weeks.  At the first visit, all individuals underwent an ophthalmic 152 
examination including, color fundus photography (Topcon 3D OCT-1000, Topcon Corp, 153 
Tokyo, Japan) and spectral domain optical coherence tomography (SD-OCT; macular 154 
volume scans; Cirrus HD-OCT, Carl Zeiss Meditec, Inc., Dublin, CA).  The ocular healthy 155 
individuals additionally underwent SAP with the Humphrey Field Analyzer (HFA 740i, Central 156 
30-2 Test, SITA Fast). 157 
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 158 
At both visits, microperimetry was undertaken with the MAIA (Macular Integrity and 159 
Assessment microperimeter; CenterVue, Padova, Italy) using a custom grid comprising 40 160 
stimulus locations, with an inter-stimulus separation of 2°, extending out to 7° eccentricity 161 
(Goldmann size III; 200 msec stimulus duration; 1.27 cdm-2 background luminance;  162 
318 cdm-2 maximum stimulus luminance; 4-2 dB double reversal of threshold).  Fixation loss 163 
catch trials were determined with the Heijl-Krakau blind spot technique. The upper limit of 164 
acceptability for incorrect responses to the fixation catch trials was 15%.  False-positive and 165 
false-negative catch trials are not implemented on the MAIA.  However, the blind spot 166 
technique in microperimetry is not equivalent to that in SAP since microperimeters 167 
incorporate fundus tracking to identify, and correct for, fixation errors. The presentation of 168 
the stimulus at the center of the blind spot in an individual with a fixation loss corrected by 169 
fundus tracking could, therefore, theoretically, be considered to represent a false-positive 170 
catch trial. 171 
 172 
The microperimetry results from the first visit for the ocular healthy individuals and for those 173 
with AMD were discarded to reduce the influence of any perimetric learning effect30.   174 
 175 
 176 
Derivation of the Total and Pattern Deviation values from the group of ocular healthy 177 
individuals 178 
The measured sensitivity as a function of age was determined at each stimulus location 179 
using ordinary least squares linear regression.  The assumptions of linear regression31 were 180 
met at each of the 40 stimulus locations.  The outcome of the linear regression at each 181 
location was then validated by bootstrapping based upon 1000 replications32.  The 182 
bootstrapped regression coefficients and the bias-corrected and accelerated33 95% 183 
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confidence intervals were estimated from the bootstrap distribution for each stimulus 184 
location.   185 
 186 
The distributions of the Total and of the Pattern Deviation values at each location were 187 
derived for each of the two methods.  The Pattern Deviation values were obtained by the 188 
general height adjustment 9,34, defined as the 85th percentile of the distribution of the Total 189 
Deviations.  The deviations corresponding to the probability levels at 5%, 2% and 1% were 190 
then calculated for each method.  A liberal approach to the selection of probability levels was 191 
adopted and the 0.5% level was therefore omitted.  192 
 193 
 194 
Application of the Pattern Deviation probability analysis to the individuals with AMD  195 
The Pattern Deviation probability analysis for each of the two methods was separately 196 
applied to the measured sensitivity at each stimulus location for each individual with AMD, 197 
given that the visual field loss in AMD is focal35–38.   198 
 199 
 200 
Statistical analysis 201 
For the ocular healthy individuals, normality was confirmed for the distributions at each 202 
stimulus location of the Total and of the Pattern Deviation values, derived by the age-specific 203 
and by the central tendency methods, using the Kolmogorov-Smirnov test. 204 
 205 
The difference, for the ocular healthy individuals, between the age-specific and the central 206 
tendency methods in the magnitude of the Total Deviation values required for each 207 
probability level was evaluated using a repeated measures ANOVA.  The within-subject 208 
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factors were method (age-specific or central tendency) and probability level.  The between-209 
subject factors were eccentricity and age.  An identical ANOVA was undertaken for the 210 
Pattern Deviation values. 211 
 212 
For the individuals with AMD, the difference between the age-specific and the central 213 
tendency methods in the number of stimulus locations exhibiting abnormality (at p≤5%) by 214 
Pattern Deviation probability analysis was evaluated using a repeated-measures ANOVA.  215 
The within-subject factor was method and the between-subject factor was eccentricity. 216 
 217 
Results 218 
The demographic, visual acuity and visual field characteristics of the ocular healthy 219 
individuals and of those with AMD are shown in Table 1.  220 
 221 
Table 1. The demographic, visual acuity and visual field characteristics of the ocular healthy 222 
individuals and of those with age-related macular degeneration.  223 
 224 
 
Normal 
N=66 
AMD* 
N=45 
Age (years) 
    Median (IQR†) 
    Mean (SD‡) 
    Range 
 
43.0 (26.0, 65.0) 
45.9 (20.8) 
19 to 93 
 
80.0 (75.0, 83.0) 
78.6 (7.8) 
55 to 91 
Gender  
    (male/female) 
 
28 / 38 
 
18 / 27 
VA§ (LogMAR; Snellen) 
   Median  
   (IQR) 
   Mean (SD) 
   Range 
 
-0.1; 6/5    
(-0.2; 6/4, -0.1; 6/5) 
-0.1; 6/5 (0.1; 6/7.5) 
-0.2; 6/4 to 0.18 6/9 
 
0.2; 6/9  
(0.1; 6/7.5, 0.3; 6/12) 
0.3; 6/12 (0.2; 6/9) 
0; 6/6 to 0.9; 6/48 
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SAP|| 
Mean Deviation (dB) 
   Median (IQR) 
   Mean (SD) 
   Range 
Pattern Standard Deviation (dB) 
   Median (IQR) 
   Mean (SD) 
   Range 
 
 
-0.3 (-1.0, 0.5) 
-0.3 (2.0) 
-7.3 to 1.58 
 
1.5 (1.3, 1.8) 
1.7 (0.8) 
0.63 to 5.9 
 
 
- 
 
 
 
- 
Microperimetry  
Mean Sensitivity (dB) 
   Median (IQR) 
   Mean (SD) 
   Range 
 
 
29.8 (28.6, 30.5) 
29.5 (1.7) 
22.7 to 32.5 
 
 
23.0 (19.3, 25.2) 
21.5 (5.8) 
5.4 to 31.4 
 225 
* Age-related macular degeneration  226 
† interquartile range  227 
‡ standard deviation  228 
§ visual acuity  229 
|| standard automated perimetry  230 
 231 
 232 
Of the 45 individuals with AMD, 2 exhibited early, 6 intermediate and 37 late AMD. Of the 233 
latter, 34 had neovascular and 3 had atrophic disease.  All individuals with neovascular AMD 234 
had received anti-vascular endothelial growth factor therapy.  235 
 236 
For the ocular healthy individuals, the regression coefficient of sensitivity against age at each 237 
stimulus location was identical to that of the bootstrapped regression coefficient 238 
(Supplementary Table S1).  The 95% confidence intervals of the regression coefficient were 239 
negative at all but two locations and exhibited almost identical values to the bootstrapped 240 
95% confidence intervals (Supplementary Table S1).   241 
 242 
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The central tendency method was referenced to the median age of the ocular healthy 243 
individuals, 43.0 years.   244 
 245 
The distributions of both the Total and the Pattern Deviations at each of the 40 stimulus 246 
locations was Gaussian (Kolmogorov-Smirnov, range: p = 0.072 to p=0.200) for both the 247 
age-specific and the central tendency methods.   248 
 249 
The Pattern Deviation value for the designation of abnormality at each probability level was 250 
less negative for the central tendency method than for the age-specific method (p<0.001) by 251 
up to 2.4dB (Figure 1) and was independent of age (p=0.956) (Supplementary Table S2).  252 
The magnitude of the differences between the two methods, overall, became less 253 
pronounced with increasing eccentricity (p=0.003).  Thus, the central tendency method will 254 
detect shallower (i.e., less deep) focal abnormality compared to the age-specific method.   255 
 256 
For the individuals with AMD, the difference between the age-specific and central tendency 257 
methods in the designation of visual field loss is shown in Figure 2.  As expected, the 258 
number of locations exhibiting abnormality by Pattern Deviation probability analysis was 259 
greater for the central tendency method than for the age-specific method (Figure 2) 260 
(p<0.001).  The difference between the two methods was most apparent at the 5% 261 
probability level and reduced as the likelihood of abnormality increased (Figure 2 top row).  262 
At some locations, the central tendency method designated a greater likelihood of 263 
abnormality by up to three probability levels (Figure 2, bottom right).   264 
 265 
The number of locations exhibiting abnormality by Pattern Deviation probability analysis for 266 
each method in relation to the microperimetry color designation of sensitivity is shown in 267 
Figure 3.  The range of sensitivities designated in orange exhibited the greatest discrepancy 268 
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(Figure 3 right panel).   Of the 478 locations exhibiting an orange designation, 170 locations 269 
(36%) were normal by the central tendency Pattern Deviation probability analysis and 220 270 
(46%) were abnormal at the 1% probability level.  Similarly, 272 (56%) of these 478 locations 271 
were designated as normal and 87 locations (18%) as abnormal at the 1% probability level 272 
by the age-specific Pattern Deviation probability analysis.  273 
 274 
In 16 of the individuals with AMD, the number of locations exhibiting abnormality by Pattern 275 
Deviation probability analysis by either method was greater than the number exhibiting a 276 
color designation of orange, red or black.  Five such cases are illustrated in Figure 4.   277 
 278 
 279 
Discussion 280 
This study derived Pattern Deviation probability values for microperimetry from an 281 
independently acquired group of ocular healthy individuals and applied these to a group of 282 
individuals with AMD.  The purpose of the study was to evaluate the relationship between 283 
the color designation of abnormality and that defined by the Pattern Deviation probability 284 
analysis. 285 
 286 
The key finding from this study was that the orange designation of absolute sensitivity can 287 
represent either a normal or an abnormal outcome by Pattern Deviation probability analysis. 288 
Obviously, caution should be exercised in the interpretation of sensitivity values displayed in 289 
orange. However, the findings also indicate a need for location and age-adjusted normal 290 
values, and the associated probability analysis in microperimetry.  Sensitivity values 291 
designated in orange encompassed the entire range of Pattern Deviation probability levels 292 
from normal to p≤1%, for both the age-specific and the central tendency methods.  The 293 
orange designation can, therefore, indicate either normality or abnormality and is inadequate 294 
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compared to a probability-based interpretation, in which the degree of certainty of 295 
abnormality is clearly defined for the clinician.   296 
 297 
The limitations of the orange designation will be emphasized, in the absence of the general 298 
height adjustment,10 by the presence of diffuse loss arising from cataract.  In the absence of 299 
the Total and Pattern Deviation analysis, the presence of a cataract, in an otherwise normal 300 
visual field, will shift a given color designation from green to orange or from orange to red.  301 
With focal loss in the presence of cataract, this shift will exacerbate the depth of focal loss.  302 
These limitations would lead to erroneous clinical judgement 303 
 304 
Those locations designated in either red or black were almost entirely associated with the 305 
p≤1% probability level, for both methods.  Those in green were almost entirely associated 306 
with normality, and this was particularly apparent for the age-specific method.   307 
 308 
The purpose of the study was not to determine which of the two methods gave the ‘better’ 309 
Pattern Deviation probability levels, given the absence of a reference standard.  However, 310 
the central tendency method designated a greater likelihood of abnormality compared to the 311 
age-specific method.  The former is the method utilised in the HFA.  An evaluation of the 312 
structure-function relationship pertaining to microperimetry in AMD was also beyond the 313 
scope of the study. 314 
 315 
The accuracy of the prediction intervals is predicated on the size of the group of ocular 316 
healthy individuals.  The composition and size of the group followed that of the ISO 12866 317 
recommendation 27. The adequacy of the number of ocular healthy individuals was verified 318 
by bootstrapping which confirmed that the regression coefficients did not differ from that of a 319 
larger population.  The use of bootstrapping is an accepted technique used for internal 320 
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validation in predictive modelling 39 and has been applied to confirm the validity of outcomes 321 
in studies of visual function 40,41.   322 
 323 
The Mean Sensitivity index declined with age (regression coefficient -0.04 dB/year, R2 = 324 
0.30, p<0.001).  This outcome is consistent with that of -0.01 to -0.02 dB/year for 325 
microperimetry 42–44 and of -0.04 to -0.08 dB/year for SAP within 10° 15,17.  In addition, the 326 
ranges of sensitivity values are consistent with those reported for ocular healthy individuals 327 
45,46 and for those with AMD 47,48. 328 
 329 
A limitation of the study is that the conclusion refers to those with AMD and warrants 330 
evaluation in visual field loss arising from other disease entities.  The findings from the 331 
current study apply to those with central fixation.  A method of spatial interpolation both of 332 
sensitivity values and probability levels could be undertaken for individuals with eccentric 333 
fixation 22.  334 
 335 
The study was translational to clinical practice in that the outcome of the color coding of 336 
sensitivity was compared with the Pattern Deviation probability analysis based upon age-337 
corrected normal values of sensitivity derived from ocular healthy individuals. The latter 338 
conformed to the inclusion criteria used for the compilation of normative values in the 339 
Humphrey Field Analyzer49,50 the Matrix perimeter19 and the Octopus perimeters51,52.  An 340 
alternative design would have been to utilize a control, i.e., a ‘non-AMD’, group in which the 341 
characteristics, e.g., age, type and extent of cataract etc, would have been matched to those 342 
with AMD. The outcome of such an approach, although of scientific merit, would not have 343 
reflected clinical practice and would have limited the translational relevance of the study, as 344 
designed. 345 
 346 
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In conclusion, the findings highlight the necessity for Total and Pattern Deviation probability 347 
analysis in microperimetry, the absence of which emphasises the inappropriate color 348 
designation of sensitivity.  The evidence base indicates the following clinical 349 
recommendations for individuals with AMD for the MAIA. In AMD, sensitivity values 350 
designated in green and red/black are likely to reflect normality and true dysfunction, 351 
respectively, and those in orange should not be used to infer either normality or abnormality.  352 
For microperimeters that only employ a color designation, the significant advantage of 353 
fundus tracking is undermined by the omission of appropriate probability analyses that 354 
separate focal from overall loss.   355 
 356 
 357 
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Figures 491 
 492 
 493 
Figure 1. The Total and Pattern Deviation (TD and PD) values derived from the ocular 494 
healthy individuals by the age-specific (grey) and central tendency (black) methods, at each 495 
of four annuli represented by the magnitude of sensitivity and deviation from normal (top and 496 
bottom, respectively). The Total Deviation is the difference at each stimulus location 497 
between the measured sensitivity and the age-corrected normal value. The Pattern 498 
Deviation is the corresponding difference having corrected for any overall departure from the 499 
age-corrected normal hill of vision.  (Top) The magnitude of sensitivity designated as normal 500 
and corresponding to the 5%, 2% and 1% probability levels are shown for a 45 and a 75 501 
year old individual.  The horizontal dashed line represents the upper limit of the sensitivity 502 
values designated in orange on the MAIA ‘printout’.  (Bottom) The corresponding Total (left) 503 
and Pattern (right) Deviation values at each probability level for both ages are also shown.   504 
 505 
 506 
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 507 
Figure 2.  The agreement between the age-specific and central tendency methods in 508 
individuals with age-related macular degeneration.  The agreement is shown between the 509 
number of locations exhibiting abnormality by Pattern Deviation (PD) at probability levels of 510 
5% (top left), 2% (top middle) and 1% (top right), respectively.  The cumulative frequency 511 
curves (bottom left) show the number of locations exhibiting abnormality by PD probability 512 
analysis, for each method.  The number of locations exhibiting abnormality at a probability 513 
level of 5%, 2% and 1% are shown by solid, dashed and dotted lines, respectively (bottom 514 
left).  The agreement in the PD probability level at each location, for each method is also 515 
illustrated (bottom right). 516 
 517 
 518 
 519 
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 520 
Figure 3. The number of locations exhibiting normality and abnormality in individuals with 521 
age-related macular degeneration.  The left panel shows the color designation for each 522 
value of sensitivity in relation to the Pattern Deviation probability level (normal [pale grey] 523 
and p<5% [grey], p<2% [dark grey] and p<1% [black]), for the age-specific (left top) and the 524 
central tendency (left bottom) methods.  The pie charts show the outcome of the Pattern 525 
Deviation probability analysis defined by each method for all locations for all individuals in 526 
relation to the color designation.  The corresponding number of locations is given in the 527 
center of each chart, the size of which is scaled logarithmically. N=normal. 528 
 529 
 530 
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 531 
 532 
Figure 4. Five cases of age-related macular degeneration (top to bottom: aged 76, 67, 79, 74 533 
and 80 years, respectively).  Each panel from left to right shows the color fundus image, the 534 
SD-OCT horizontal line scan through the fovea, the MAIA infra-red image and the abnormal 535 
outcomes by Pattern Deviation probability analysis using the age-specific and central 536 
tendency method.   537 
 538 
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Supplemental Material 540 
Supplementary Table S1 541 
Coefficient of linear regression and 95% confidence intervals and corresponding 542 
bootstrapped outcomes.  543 
Stimulus location β 95% CI  Bootstrap  
β 
95% CI 
Lower Upper  Lower Upper 
Location 1 -0.036 -0.062 -0.011  -0.036 -0.063 -0.009 
Location 2 -0.053 -0.082 -0.023  -0.053 -0.083 -0.020 
Location 3 -0.048 -0.074 -0.022  -0.048 -0.077 -0.018 
Location 4 -0.043 -0.065 -0.021  -0.043 -0.065 -0.016 
Location 5 -0.026 -0.053 0.001  -0.026 -0.056 0.001 
Location 6 -0.044 -0.068 -0.019  -0.044 -0.062 -0.023 
Location 7 -0.038 -0.061 -0.015  -0.038 -0.061 -0.011 
Location 8 -0.045 -0.072 -0.019  -0.045 -0.077 -0.017 
Location 9 -0.035 -0.059 -0.012  -0.035 -0.065 -0.008 
Location 10 -0.043 -0.065 -0.021  -0.043 -0.062 -0.020 
Location 11 -0.046 -0.070 -0.022  -0.046 -0.074 -0.018 
Location 12 -0.047 -0.080 -0.013  -0.047 -0.087 -0.010 
Location 13 -0.041 -0.066 -0.017  -0.041 -0.062 -0.019 
Location 14 -0.049 -0.076 -0.023  -0.049 -0.076 -0.021 
Location 15 -0.070 -0.094 -0.046  -0.070 -0.095 -0.045 
Location 16 -0.044 -0.070 -0.018  -0.044 -0.071 -0.015 
Location 17 -0.047 -0.072 -0.022  -0.047 -0.073 -0.018 
Location 18 -0.037 -0.061 -0.013  -0.037 -0.057 -0.016 
Location 19 -0.038 -0.071 -0.006  -0.038 -0.073 -0.002 
Location 20 -0.040 -0.082 0.002  -0.040 -0.083 0.002 
Location 21 -0.053 -0.085 -0.020  -0.053 -0.090 -0.013 
Location 22 -0.049 -0.073 -0.025  -0.049 -0.074 -0.020 
Location 23 -0.048 -0.075 -0.021  -0.048 -0.076 -0.022 
Location 24 -0.051 -0.081 -0.021  -0.051 -0.090 -0.016 
Location 25 -0.057 -0.082 -0.032  -0.057 -0.090 -0.025 
Location 26 -0.040 -0.063 -0.016  -0.040 -0.065 -0.015 
Location 27 -0.036 -0.060 -0.012  -0.036 -0.059 -0.014 
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Location 28 -0.049 -0.088 -0.010  -0.049 -0.083 -0.015 
Location 29 -0.040 -0.063 -0.017  -0.040 -0.065 -0.013 
Location 30 -0.055 -0.083 -0.027  -0.055 -0.081 -0.026 
Location 31 -0.044 -0.065 -0.023  -0.044 -0.069 -0.020 
Location 32 -0.051 -0.071 -0.031  -0.051 -0.070 -0.031 
Location 33 -0.052 -0.078 -0.026  -0.052 -0.077 -0.023 
Location 34 -0.042 -0.067 -0.017  -0.042 -0.070 -0.015 
Location 35 -0.033 -0.060 -0.006  -0.033 -0.060 -0.008 
Location 36 -0.041 -0.065 -0.017  -0.041 -0.073 -0.011 
Location 37 -0.047 -0.076 -0.017  -0.047 -0.072 -0.019 
Location 38 -0.048 -0.076 -0.021  -0.048 -0.081 -0.019 
Location 39 -0.043 -0.069 -0.018  -0.043 -0.085 -0.013 
Location 40 -0.036 -0.063 -0.009  -0.036 -0.062 -0.008 
  544 
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Supplementary Table S2 545 
Outcomes from the repeated measures ANOVA for the difference between the age-specific 546 
and central tendency methods for the Total and for the Pattern Deviation values.   547 
 Total Deviation Pattern Deviation 
 F p F p 
Method 495.63 <0.001 438.05 <0.001 
Probability Level 684.12 <0.001 1168.51 <0.001 
Age 1.85 0.142 0.02 0.996 
Eccentricity 6.56 <0.001 7.99 <0.001 
Method*Age 14.89 <0.001 0.11 0.956 
Method*Eccentricity 9.28 <0.001 3.79 0.003 
Method*Probability Level 16.55 <0.001 17.90 <0.001 
Probability Level*Age 0.00 1.000 0.00 1.000 
Probability 
level*Eccentricity  
5.16 <0.001 7.40 <0.001 
Age*Eccentricity 0.003 1.000 0.001 1.000 
Method*Probability 
Level*Age 
0.004 1.000 0.01 1.000 
     
Method*Age* 
Eccentricity 
0.02 1.000 0.00 1.000 
Method*Probability 
Level*Eccentricity 
5.66 <0.001 7.45 <0.001 
Probability 
level*Age*Eccentricity 
0.00 1.000 0.00 1.000 
Method*Probability 
Level*Age*Eccentricity 
0.00 1.000 0.00 1.000 
 548 
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